FR2822238B1 - Methode et trousse pour le suivi des maladies neurodegeneratives - Google Patents

Methode et trousse pour le suivi des maladies neurodegeneratives

Info

Publication number
FR2822238B1
FR2822238B1 FR0103592A FR0103592A FR2822238B1 FR 2822238 B1 FR2822238 B1 FR 2822238B1 FR 0103592 A FR0103592 A FR 0103592A FR 0103592 A FR0103592 A FR 0103592A FR 2822238 B1 FR2822238 B1 FR 2822238B1
Authority
FR
France
Prior art keywords
kit
neurodegenerative diseases
monitoring neurodegenerative
monitoring
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0103592A
Other languages
English (en)
Other versions
FR2822238A1 (fr
Inventor
Michel Geffard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEMAC SA
Original Assignee
GEMAC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0103592A priority Critical patent/FR2822238B1/fr
Application filed by GEMAC SA filed Critical GEMAC SA
Priority to PCT/FR2002/000927 priority patent/WO2002075274A2/fr
Priority to US10/471,788 priority patent/US7195881B2/en
Priority to EP02713027A priority patent/EP1399743A2/fr
Priority to JP2002573641A priority patent/JP2004530871A/ja
Priority to CNA028066081A priority patent/CN1511258A/zh
Priority to CA002441170A priority patent/CA2441170A1/fr
Publication of FR2822238A1 publication Critical patent/FR2822238A1/fr
Application granted granted Critical
Publication of FR2822238B1 publication Critical patent/FR2822238B1/fr
Priority to NO20034080A priority patent/NO20034080L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
FR0103592A 2001-03-16 2001-03-16 Methode et trousse pour le suivi des maladies neurodegeneratives Expired - Fee Related FR2822238B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0103592A FR2822238B1 (fr) 2001-03-16 2001-03-16 Methode et trousse pour le suivi des maladies neurodegeneratives
US10/471,788 US7195881B2 (en) 2001-03-16 2002-03-15 Method and kit for following neurodegenerative diseases
EP02713027A EP1399743A2 (fr) 2001-03-16 2002-03-15 Methode et trousse pour le suivi des maladies neurodegeneratives
JP2002573641A JP2004530871A (ja) 2001-03-16 2002-03-15 神経変性疾患の管理のための方法及びキット
PCT/FR2002/000927 WO2002075274A2 (fr) 2001-03-16 2002-03-15 Methode et trousse pour le suivi des maladies neurodegeneratives
CNA028066081A CN1511258A (zh) 2001-03-16 2002-03-15 神经退行性疾病的监控方法和所用试剂盒
CA002441170A CA2441170A1 (fr) 2001-03-16 2002-03-15 Methode et trousse pour le suivi des maladies neurodegeneratives
NO20034080A NO20034080L (no) 2001-03-16 2003-09-15 Fremgangsmåte og sett for deteksjon av neurodegenerative sykdommer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103592A FR2822238B1 (fr) 2001-03-16 2001-03-16 Methode et trousse pour le suivi des maladies neurodegeneratives

Publications (2)

Publication Number Publication Date
FR2822238A1 FR2822238A1 (fr) 2002-09-20
FR2822238B1 true FR2822238B1 (fr) 2003-08-29

Family

ID=8861210

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0103592A Expired - Fee Related FR2822238B1 (fr) 2001-03-16 2001-03-16 Methode et trousse pour le suivi des maladies neurodegeneratives

Country Status (8)

Country Link
US (1) US7195881B2 (fr)
EP (1) EP1399743A2 (fr)
JP (1) JP2004530871A (fr)
CN (1) CN1511258A (fr)
CA (1) CA2441170A1 (fr)
FR (1) FR2822238B1 (fr)
NO (1) NO20034080L (fr)
WO (1) WO2002075274A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822238B1 (fr) 2001-03-16 2003-08-29 Gemac Methode et trousse pour le suivi des maladies neurodegeneratives
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
AU2004248155B2 (en) 2003-06-09 2008-10-23 Redox-Reactive Reagents L.L.C. Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
US7840270B2 (en) * 2003-07-23 2010-11-23 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US7962215B2 (en) 2004-07-23 2011-06-14 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
CN101506236B (zh) 2005-11-30 2012-12-12 雅培制药有限公司 抗淀粉样β蛋白的单克隆抗体及其用途
US20080097153A1 (en) * 2006-08-24 2008-04-24 Ignagni Anthony R Method and apparatus for grasping an abdominal wall
US8455626B2 (en) * 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008098001A2 (fr) * 2007-02-05 2008-08-14 Synapse Biomedical, Inc. Électrode intramusculaire amovible
EP2486928A1 (fr) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Procédé pour le traitement des amyloses
WO2008144578A1 (fr) * 2007-05-17 2008-11-27 Synapse Biomedical, Inc. Dispositifs et procédés pour évaluer l'électromyogramme d'un point moteur en tant que biomarqueur
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
WO2009059033A1 (fr) * 2007-10-30 2009-05-07 Synapse Biomedical, Inc. Procédé d'amélioration des apnées du sommeil
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
JP6147665B2 (ja) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド アミロイドベータ結合タンパク質
RU2693627C2 (ru) * 2017-11-03 2019-07-03 Общество С Ограниченной Ответственностью "Валента - Интеллект" Комбинации эдаравона для лечения ишемических повреждений мозга
US11471683B2 (en) 2019-01-29 2022-10-18 Synapse Biomedical, Inc. Systems and methods for treating sleep apnea using neuromodulation
FR3094493A1 (fr) * 2019-04-01 2020-10-02 Polyneuros Procédé de détection ou de suivi de l’évolution d’une maladie chronique auto-immune par dosage immunologique
FR3094492A1 (fr) * 2019-04-01 2020-10-02 Polyneuros Procédé de détection ou de suivi de l’évolution d’une maladie chronique dégénérative par dosage immunologique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550799B1 (fr) * 1983-08-17 1986-02-21 Commissariat Energie Atomique Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
BE1006974A3 (fr) * 1993-04-23 1995-02-07 Anda Biolog Sa Procede de detection et/ou de quantification de differentes classes d'immunoglobulines specifiques d'une pathologie comportant une reponse auto-immunitaire.
FR2762602B1 (fr) * 1997-04-28 1999-06-04 Inst Nat Sante Rech Med Moyens pour la detection precoce de pathologies auto-immunes inflammatoires
FR2822238B1 (fr) 2001-03-16 2003-08-29 Gemac Methode et trousse pour le suivi des maladies neurodegeneratives

Also Published As

Publication number Publication date
CN1511258A (zh) 2004-07-07
JP2004530871A (ja) 2004-10-07
NO20034080D0 (no) 2003-09-15
CA2441170A1 (fr) 2002-09-26
EP1399743A2 (fr) 2004-03-24
WO2002075274A2 (fr) 2002-09-26
FR2822238A1 (fr) 2002-09-20
NO20034080L (no) 2003-11-14
US20040082015A1 (en) 2004-04-29
US7195881B2 (en) 2007-03-27
WO2002075274A3 (fr) 2003-12-11

Similar Documents

Publication Publication Date Title
FR2822238B1 (fr) Methode et trousse pour le suivi des maladies neurodegeneratives
DE60218406D1 (de) Ophthalmische Vorrichtung
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
DE60201228D1 (de) Werkstück Entladegerät und Methode
NO20040353L (no) Ny terapeutsk metode
DE60311088D1 (de) Filterapparat und methode
DE50204416D1 (de) Echosignalüberwachungsvorrichtung und -verfahren
DE60223661D1 (de) Drahtlos programmierbare logische vorrichtung
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
DE60138995D1 (de) Betrugssicheres Verarbeitungsverfahren
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DE60231538D1 (de) Sputtertarget und herstellungsverfahren dafür
NO20035224D0 (no) Oftalmisk pirenzepingel
DE60133956D1 (de) Gewindebohrgerät und Methode
EP1646353A4 (fr) Proteines de fusion destinees au traitement du systeme nerveux central
ATE360674T1 (de) Hydrierverfahren
EP1450820A4 (fr) Methode de traitement et de prevention de maladies inflammatoires
IS3004B (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
AU2003259833A8 (en) Methods of treating neurodegenerative diseases
DK1639107T3 (da) Forbedrede proteaser og fremgangsmåder til fremstilling deraf
DE60218267D1 (de) Wiedergabeverfahren und Vorrichtung
EP1386001A4 (fr) Trousses et methodes permettant d'evaluer le stress oxydatif
HUP0400066A3 (en) Method and means for detecting gluten-induced diseases
AU2002362488A1 (en) Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
EP1619538A4 (fr) Methode de selection de lentille de contact et/ou de systeme de soins associe

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130